Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
Public ClinicalTrials.gov record NCT00851045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Phase II Trial of CT-322 (BMS-844203) Plus Irinotecan, 5-FU and Leucovorin (FOLFIRI) Versus Bevacizumab Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy of CT-322 comparative to bevacizumab, both in combination with irinotecan, 5-FU and leucovorin in the second-line treatment of subject with metastatic colorectal cancer
Study identification
- NCT ID
- NCT00851045
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 17 participants
Conditions and interventions
Conditions
Interventions
- Irinotecan Drug
- 5-Fluorouracil (bolus) Drug
- 5-Fluorouracil (infusional) Drug
- Leucovorin calcium Drug
- CT-322 Drug
- Bevacizumab Drug
- Bevacizumab Placebo (saline solution) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2009 (Type not available)
- Primary completion
- Sep 2011 (Actual)
- Completion
- Oct 2011 (Actual)
- Last update posted
- Oct 12, 2015
2009 – 2011
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Acrc/Arizona Clinical Research Center, Inc. | Tucson | Arizona | 85715 | — |
| Compassionate Cancer Care Medical Group Inc | Fountain Valley | California | 92708 | — |
| Compassionate Cancer Care Medical Group, Inc | Riverside | California | 92501 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33916 | — |
| Midwest Center For Hematology/Oncology | Joliet | Illinois | 60432 | — |
| Cancer Center Of Kansas | Wichita | Kansas | 67214 | — |
| Gurtler, Jayne | Metairie | Louisiana | 70006 | — |
| Guthrie Clinic, Ltd | Sayre | Pennsylvania | 18840 | — |
| Pharma Resource | East Providence | Rhode Island | 02915 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| University Of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00851045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2015 · Synced Oct 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00851045 live on ClinicalTrials.gov.